Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mrudula B. Glassberg"'
Autor:
Mrudula B. Glassberg, Sudip Ghosh, Jeffrey W. Clymer, George W. J. Wright, Nicole Ferko, Joseph F. Amaral
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-17 (2019)
Abstract Background Hepatic resection (HR) is the gold standard liver cancer treatment, but few patients are eligible due to comorbidities or tumor location. Microwave ablation (MWA) is an important complementary liver cancer treatment to HR. This sy
Externí odkaz:
https://doaj.org/article/eb3819f9e4b44055a98d167a84c047db
Autor:
Khaled M. Musallam, Ali T. Taher, John B. Porter, Antonis Kattamis, Mrudula B. Glassberg, Luciana Bueno, Jeevan K. Shetty, Frederik Lersch, Barbara Rosettani, Maria Domenica Domenica Cappellini
Publikováno v:
Blood. 140:5358-5359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5d2e1d1db122b43adc6b5860ff04688
https://doi.org/10.1182/blood-2022-157113
https://doi.org/10.1182/blood-2022-157113
Autor:
Maria Domenica Domenica Cappellini, Aylin Yucel, Juliana Meyers, Maria Jimenez, Tram Nham, Mrudula B. Glassberg, Ferras Alashkar
Publikováno v:
Blood. 140:10877-10878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f54001640e64bf8b3e3f2942ad93bc72
https://doi.org/10.1182/blood-2022-156549
https://doi.org/10.1182/blood-2022-156549
Publikováno v:
The Journal of arthroplasty. 34(8)
Background This study evaluated the trends in anticoagulation use after total hip arthroplasty (THA), and the effectiveness and safety of rivaroxaban compared to warfarin. Methods This retrospective database analysis used healthcare claims from the T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a69cb2e8164cf9f11b7f83e87cc326
https://pubmed.ncbi.nlm.nih.gov/31005440
https://pubmed.ncbi.nlm.nih.gov/31005440
Autor:
Mrudula B. Glassberg, Behnam Sadeghirad, George W.J. Wright, Jeffrey W. Clymer, Nicole Ferko, Joseph F. Amaral, Sudip Ghosh, Rana A. Qadeer
Publikováno v:
OncoTargets and therapy
Mrudula B Glassberg,1 Sudip Ghosh,2 Jeffrey W Clymer,3 Rana A Qadeer,4 Nicole C Ferko,4 Behnam Sadeghirad,4 George WJ Wright,4 Joseph F Amaral21Health Economics and Market Access, Ethicon Inc, Somerville, NJ, USA; 2Health Economics and Market Access,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85c1d0b60dd3fa90aafb267aa47ffc0
https://pubmed.ncbi.nlm.nih.gov/31496742
https://pubmed.ncbi.nlm.nih.gov/31496742
Publikováno v:
Respiratory medicine. 145
Background It is unknown whether there is a benefit to initiating triple therapy (TT; inhaled corticosteroids combined with long-acting β2-agonists and long-acting muscarinic antagonists) promptly (within 30 days) following a chronic obstructive pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e7bac107470009852d7435e7eb8dd5
https://pubmed.ncbi.nlm.nih.gov/30509702
https://pubmed.ncbi.nlm.nih.gov/30509702